-First Post Predictably, the recommendation by an experts’ panel appointed by the Supreme Court  - that trials of genetically modified (GM) crops should be halted for 10 years – has stirred a hornet’s nest. Such a moratorium would include ongoing trials and the court rejected it. This follows on the heels of the Parliamentary Standing Committee on Agriculture’s 492-page report published in August which asked for the banning of GM food crops...

-The Hindu A day after the Union Government rolled out cash transfer for subsidies and entitlements, Jan Sansad, a coalition of more than 60 people’s movement, rejected it for being “anti-people”. Terming the scheme “an attempt by the government to wash off its hands from the responsibility to provide basic services and social security to its citizens”, the coalition said direct cash transfer will have disastrous impact on the lives of the...

-DNA For the first time, Maharashtra has officially admitted that cotton yield is likely to reduce by nearly 40%. Bt cotton failure in more than 4 million hectares of land has reduced cotton yieldfrom 3.5 million quintal to 2.2 million quintal. A report sent by the state agricultural department to the Centre states that the estimate of the net direct economic loss to cotton farmers in the state will be nearly Rs6,000...

-One World South Asia Reducing incomes, stagnating yields, increasing costs of cultivation, fragmenting of land-holdings and reducing of institutions credit facilities plot the graph of farmers' suicides in India. A national consultation and public hearing on framers' suicides being organised by Action Aid in the capital brought together experts and policy critics to evaluate the progress of government initiatives to respond to the ongoing agrarian crisis. Suicides are only one extreme symptom of...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...